Dr. MORCEL SOFIE
ActiveSummary
Dr. MORCEL SOFIE has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1,000 and a net result of €316,855. Equity is shrinking by about 29% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2026. Its solvency ranks better than 5% of 20,490 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
27-04
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
14-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Highest result from 2021 to 2025net €328,640 ▲12.6%
Operating result €433,804, net result €328,640, both a record.
15-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial
Liquidity more than quadruplescurrent ratio 42.27
Current ratio from 10.01 to 42.27; short-term debt falls from €55,641 to €18,898.
31-12
Financial
Equity above €500,000equity €790,171 ▲58.6%
A profit in every financial year since 2021 builds equity to €790,171.
28-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial
Equity above €200,000equity €498,250 ▲161%
A profit in every financial year since 2021 builds equity to €498,250.
26-07
NBB filing
Annual accounts filed
financial year 2021 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.